When to Hold DAPT for Stents and Duration of Interruption
For elective surgery, hold the P2Y12 inhibitor (clopidogrel 5-7 days, prasugrel 7-10 days, ticagrelor 3-5 days) while continuing aspirin, but only after completing the minimum mandatory DAPT duration based on stent type and clinical indication 1, 2, 3.
Mandatory DAPT Duration Before ANY Interruption is Considered
You cannot hold DAPT during these critical periods without accepting catastrophic stent thrombosis risk:
- Drug-eluting stents (DES) in stable disease: Minimum 6 months (3 months if surgery absolutely cannot be delayed) 1, 4
- Any stent in ACS patients: Minimum 12 months 1
- Bare-metal stents (BMS): Minimum 4 weeks 1, 5
After these mandatory periods, elective surgery can proceed with selective P2Y12 inhibitor interruption.
Perioperative Management Algorithm
Step 1: Determine Hemorrhagic Risk of Procedure
Major hemorrhagic risk (cannot proceed on any antiplatelet): Intracranial surgery, posterior eye surgery, major ENT procedures, prostate surgery, extensive tissue detachment 4, 3
Intermediate risk (can proceed on aspirin alone): Most general surgical procedures 4
Minor risk (can proceed on full DAPT): Dental procedures, minor dermatologic procedures 4
Step 2: Apply Time-Based Strategy
If within mandatory DAPT period and surgery cannot be delayed:
- Major hemorrhagic risk: Stop both agents 5 days before surgery (accept high thrombotic risk) OR consider bridge therapy with short-acting IV agents (cangrelor, tirofiban, eptifibatide) 4, 3
- Intermediate risk: Continue aspirin, stop P2Y12 inhibitor 5 days before 4
- Minor risk: Continue both agents 4
If beyond mandatory DAPT period:
- Major hemorrhagic risk: Stop both agents with appropriate washout periods 3
- Intermediate risk: Continue aspirin, stop P2Y12 inhibitor with drug-specific washout 3
- Minor risk: Continue both agents 4
Drug-Specific Washout Periods
The P2Y12 inhibitor must be stopped for adequate platelet function recovery:
- Clopidogrel: 5-7 days 3, 4
- Prasugrel: 7-10 days (FDA label states "at least 7 days") 2, 3
- Ticagrelor: 3-5 days 3
Aspirin should be continued throughout the perioperative period whenever hemorrhagic risk permits 4, 1.
Critical Timing Considerations
Postpone elective surgery if possible:
Resume therapy immediately postoperatively - consider clopidogrel loading dose of at least 300 mg 4. The FDA label warns that stopping prasugrel increases risk of subsequent cardiovascular events 2.
Special Circumstances
CABG surgery: Prasugrel should be discontinued at least 7 days prior 2. However, after CABG in ACS patients, resume P2Y12 inhibitor therapy postoperatively to complete 12 months total DAPT 1.
Active bleeding: If possible, manage bleeding without discontinuing therapy, as stopping increases cardiovascular event risk 2. This is the only true "indication" to hold DAPT outside of planned surgery.
High bleeding risk patients (prior bleeding on DAPT, coagulopathy, oral anticoagulant use, weight <60 kg): May consider stopping P2Y12 inhibitor after 6 months in ACS patients with DES, though this remains controversial 1.
Common Pitfalls
- Never stop DAPT for elective procedures within the mandatory duration - stent thrombosis carries 20-45% mortality
- Do not stop aspirin unless absolutely necessary - it should be the last agent discontinued 4, 1
- Do not use clopidogrel monotherapy in early ACS period - pharmacogenomic variability creates unreliable protection 6
- Avoid premature discontinuation - this is the leading cause of late stent thrombosis 2
The decision requires coordination between anesthesiology, cardiology, and surgery to balance thrombotic versus bleeding risk 3, 7.